1350837-05-6

Basic information

• Product Name: C₁₈H₂₉ClO₃Si
• Synonyms: C₁₈H₂₉ClO₃Si
• CAS NO: 1350837-05-6
• Molecular Weight: 356.965
• Mol File: 1350837-05-6.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: C₁₈H₂₉ClO₃Si(CAS DataBase Reference)
• NIST Chemistry Reference: C₁₈H₂₉ClO₃Si(1350837-05-6)
• EPA Substance Registry System: C₁₈H₂₉ClO₃Si(1350837-05-6)

Safety Data

• Hazardous Substances Data: 1350837-05-6(Hazardous Substances Data)

Upstream product

• 110-88-3 1,3,5-Trioxan 
• 1350837-04-5 C₁₇H₂₇ClO₂Si 
• 156-38-7 4-hydroxyphenylacetate 
• 27727-37-3 benzyl p-hydroxyphenylacetate 
• 1253955-44-0 benzyl 2-(4-(triisopropylsiloxy)phenyl)acetate 
• 1350837-03-4 C₁₇H₂₈O₃Si 

Downstream Products

• 1350837-06-7 C₁₈H₂₉IO₃Si 
• 1350837-08-9 C₂₆H₃₆N₄O₃Si 
• 1350837-09-0 C₁₇H₁₆N₄O₃ 
• 1350837-10-3 C₂₄H₁₉N₅O₇ 
• 1350837-11-4 C₂₅H₂₃N₅O₄ 
• 1350837-12-5 C₂₂H₂₇N₅O₁₁P₂ 

Relevant articles and documents

PROSTAGLANDIN-BISPHOSPHONATE CONJUGATE COMPOUNDS, METHODS OF MAKING SAME, AND USES THEREOF

The invention provides, in part, amino-bisphosphonate-prostaglandin conjugate compounds as well as methods for their synthesis. Said compounds may be used as EP4 agonist compounds in the prevention or treatment of conditions associated with abnormal or excessive bone loss, with abnormal or reduced bone resorption, or with abnormal calcium metabolism.